StockIQ.techElevance Health Inc. (ELV) Stock Analysis
Free AI-powered analysis and research for Elevance Health Inc. stock
Sector: Healthcare
ELV snapshot
Data as of 4 Nov 2026 close. Updated daily.
Elevance Health Inc. scores 57/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 88% of its 52-week range, up 35.9% over the past year. Latest reported figures show a profit margin of 2.5%, return on equity of 11.5% and revenue growth of +1.4%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +10
- MACD Bearish: -8
- Weak Profit Margin (2.5%): -8
- Weak Liquidity (1.47 Current Ratio): -5
- Strong Long-term Uptrend: +8
- Strong Momentum (+35.9% over 1 year): +8
- Low Volume (0.4x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ELV report
Elevance Health Inc. (ELV) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ELV Now →📰 Latest Update
CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat; Elevance Health Rises 4%, Cigna Climbs 3%
Wed, November 4, 2026 at 4:54 PM UTC 4 min read
CVS Health's stock fell 12% following its announcement to split into two companies, despite reporting better-than-expected earnings. In contrast, Elevance Health saw a 4% increase, while Cigna rose by 3%. This market reaction highlights investor concerns about CVS's restructuring plans, which may impact its future growth and operational focus, while competitors like Elevance and Cigna benefit from the uncertainty surrounding CVS.